Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
327 Leser
Artikel bewerten:
(1)

Healthcare Solutions Holdings, Inc.: Healthcare Solutions Holding, Inc., a Wholly Owned Subsidiary of Healthcare Solutions Management Group, Inc., (OTC Pink: VRTY) Announces Dr. Farhoud Khosravi as Member of the Medical Advisory Board

NEW YORK, NY / ACCESSWIRE / November 21, 2019 / Healthcare Solutions Holdings, a medical service and device company focused on providing clinicians with state-of-the-art diagnostic and therapeutic tools announced the appointment of Farhoud Khosravi, DO as member of the Medical Advisory Board.

"We look forward to the support that Dr. Farhoud Khosravi can offer HSI with our continued initiative to deliver best in class services to Gastroenterology Specialists," said Travis Revelle CEO of Healthcare Solutions Holding Inc. "Dr. Khosravi will serve a key role in identifying programs and products for delivering better patient outcomes in the practice of Gastroenterology."


Dr. Farhoud Khosravi

After completing his undergraduate studies at the University of Iowa, Dr. Farhoud Khosravi graduated from Nova Southern University of Osteopathic Medicine in 2008. He completed his residency and fellowship at Midwestern University where he received the awards of Resident, Fellow, and Teacher of the year. His clinical interests include pancreatic and biliary disorders, esophageal disease, inflammatory bowel disease and general gastroenterology. He was initially attracted to gastroenterology because of the ability to help patients with various issues from pancreatic pathology to liver disease to basic abdominal pain; he not only sees patients on a daily basis, but also performs the procedures his patients need. Outside of the office, Dr. Khosravi helps run a music label which produces music and hosts music shows.

"Once I learned about HSI, I found that it is a company that is dedicated to quite an innovative approach to deliver healthcare," says Dr. Khosravi. "This innovative approach helps provide care to patients and physicians alike. HSI is motivated and passionate, and not only dedicated to patient care but also patient outcomes. I have found that the lab testing, specifically stool studies, have been quite beneficial for me and my practice. The H-Pylori test has also been great because it helps tailor accurate antibiotic treatments for each individual patient. I have confidence that HSI will continue to be at the forefront of innovation in multiple facets of medicine from medical devices, pharmacy, lab services and beyond. Breaking through all of those markets will help expand patient care, because in the end it is all about optimizing patient care and improving patients' experiences. I think HSI can play a huge role in the healthcare space."

HSI is a medical service, and device company focused on providing clinicians with state-of-the-art diagnostic and therapeutic tools. Our mission is to improve patient outcomes by helping clinicians gain broader access to the most advanced technology in the healthcare industry. HSI does not only focus on assisting physicians with exceptional healthcare delivery, but also promoting compliance with the industry's best practices.

Healthcare Solutions, Inc., headquartered in Glen Cove, New York. Please visit www.hscorp.biz for additional information.

CONTACT:
Jonathan Loutzenhiser
SVP Healthcare Solutions
Email: IR@HScorp.Biz
Email: MR@HScorp.Biz
Phone: +1 (866) 668-2188

SOURCE: Healthcare Solutions Holdings, Inc.



View source version on accesswire.com:
https://www.accesswire.com/567593/Healthcare-Solutions-Holding-Inc-a-Wholly-Owned-Subsidiary-of-Healthcare-Solutions-Management-Group-Inc-OTC-Pink-VRTY-Announces-Dr-Farhoud-Khosravi-as-Member-of-the-Medical-Advisory-Board

© 2019 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.